| Analysis | Metabolite Name | Measured Value | Units | Feeding | Group |
|---|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 57667 | Peak area | Fed | HCR-AL |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 74971 | Peak area | Fast | HCR-AL |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 76327 | Peak area | Fast | LCR-CR |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 90309 | Peak area | Fed | HCR-CR |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 93168 | Peak area | Fed | HCR-AL |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 106517 | Peak area | Fast | HCR-AL |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 144157 | Peak area | Fed | LCR-CR |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 160412 | Peak area | Fed | HCR-CR |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 164648 | Peak area | Fast | HCR-AL |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 176338 | Peak area | Fast | LCR-CR |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 176350 | Peak area | Fast | HCR-CR |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 177495 | Peak area | Fast | LCR-CR |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 178813 | Peak area | Fed | HCR-AL |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 181999 | Peak area | Fast | HCR-CR |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 182233 | Peak area | Fast | HCR-CR |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 193323 | Peak area | Fast | LCR-CR |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 196475 | Peak area | Fed | HCR-CR |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 196700 | Peak area | Fed | LCR-CR |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 196922 | Peak area | Fed | LCR-CR |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 197280 | Peak area | Fed | HCR-CR |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 198308 | Peak area | Fast | HCR-CR |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 204668 | Peak area | Fast | LCR-CR |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 224070 | Peak area | Fast | HCR-CR |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 245458 | Peak area | Fast | LCR-CR |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 263730 | Peak area | Fed | HCR-AL |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 266532 | Peak area | Fed | HCR-CR |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 271368 | Peak area | Fed | LCR-CR |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 294901 | Peak area | Fast | HCR-AL |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 295131 | Peak area | Fast | HCR-AL |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 302777 | Peak area | Fed | LCR-AL |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 304630 | Peak area | Fast | LCR-AL |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 307602 | Peak area | Fast | LCR-AL |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 316365 | Peak area | Fast | LCR-AL |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 316818 | Peak area | Fast | LCR-AL |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 356715 | Peak area | Fed | LCR-AL |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 358019 | Peak area | Fed | LCR-AL |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 374594 | Peak area | Fed | LCR-AL |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 377524 | Peak area | Fed | LCR-AL |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 382336 | Peak area | Fed | LCR-AL |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 389925 | Peak area | Fast | LCR-AL |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 415088 | Peak area | Fed | LCR-CR |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 501993 | Peak area | Fed | LCR-CR |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 1074391 | Peak area | Fast | LCR-AL |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | Peak area | Fast | HCR-CR | |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | Peak area | Fed | HCR-AL | |
| Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | Peak area | Fed | HCR-CR | |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 21500000 | Peak area | Fed | HCR-CR |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 22300000 | Peak area | Fast | HCR-CR |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 24100000 | Peak area | Fast | HCR-CR |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 24800000 | Peak area | Fast | HCR-CR |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 25400000 | Peak area | Fast | HCR-CR |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 25700000 | Peak area | Fast | HCR-CR |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 25800000 | Peak area | Fed | LCR-CR |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 26200000 | Peak area | Fed | HCR-CR |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 26400000 | Peak area | Fast | HCR-AL |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 26400000 | Peak area | Fast | LCR-CR |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 27000000 | Peak area | Fed | HCR-CR |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 27200000 | Peak area | Fast | HCR-CR |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 27200000 | Peak area | Fed | LCR-CR |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 27900000 | Peak area | Fast | LCR-CR |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 27900000 | Peak area | Fed | HCR-CR |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 28400000 | Peak area | Fast | LCR-CR |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 28600000 | Peak area | Fast | HCR-AL |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 29200000 | Peak area | Fed | LCR-CR |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 29800000 | Peak area | Fed | HCR-AL |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 30200000 | Peak area | Fed | LCR-CR |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 30700000 | Peak area | Fast | LCR-CR |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 30900000 | Peak area | Fast | LCR-CR |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 31100000 | Peak area | Fed | HCR-AL |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 31100000 | Peak area | Fed | HCR-CR |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 31400000 | Peak area | Fed | HCR-AL |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 31700000 | Peak area | Fed | HCR-CR |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 31800000 | Peak area | Fast | HCR-AL |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 32400000 | Peak area | Fast | HCR-AL |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 32700000 | Peak area | Fast | LCR-AL |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 33300000 | Peak area | Fast | LCR-AL |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 33400000 | Peak area | Fed | LCR-AL |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 33800000 | Peak area | Fast | LCR-AL |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 33900000 | Peak area | Fast | LCR-AL |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 35200000 | Peak area | Fed | HCR-AL |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 36600000 | Peak area | Fed | LCR-AL |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 37100000 | Peak area | Fed | LCR-AL |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 37700000 | Peak area | Fed | LCR-AL |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 37800000 | Peak area | Fast | LCR-AL |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 37900000 | Peak area | Fed | LCR-AL |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 41200000 | Peak area | Fed | LCR-CR |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 44300000 | Peak area | Fed | LCR-CR |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 56500000 | Peak area | Fast | LCR-AL |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | 40923 | Peak area | Fed | HCR-CR |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | 71077 | Peak area | Fast | HCR-AL |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | 78847 | Peak area | Fast | HCR-CR |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | 87931 | Peak area | Fast | HCR-AL |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | 97652 | Peak area | Fast | LCR-AL |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | 104506 | Peak area | Fast | LCR-CR |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | 106818 | Peak area | Fast | LCR-AL |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | 107611 | Peak area | Fed | LCR-AL |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | 110519 | Peak area | Fed | LCR-AL |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | 111363 | Peak area | Fed | LCR-AL |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | 111987 | Peak area | Fast | LCR-AL |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | 114048 | Peak area | Fed | LCR-AL |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | 122269 | Peak area | Fast | LCR-AL |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | 158957 | Peak area | Fast | LCR-AL |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | Peak area | Fast | HCR-AL | |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | Peak area | Fast | HCR-CR | |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | Peak area | Fast | LCR-AL | |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | Peak area | Fast | LCR-CR | |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | Peak area | Fed | HCR-AL | |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | Peak area | Fed | HCR-CR | |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | Peak area | Fed | LCR-AL | |
| Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | Peak area | Fed | LCR-CR |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|